Literature DB >> 11788633

The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women.

Antonella Dewell1, Clarie B Hollenbeck, Bonnie Bruce.   

Abstract

Postmenopausal women are at an increased risk of developing coronary artery disease (CAD). This increase is due primarily to elevated cholesterol concentrations accompanying the loss of endogenous estrogen secretion. Recently, the consumption of soy foods has been shown to reduce serum cholesterol concentrations. Phytoestrogens (PE) have been proposed as the responsible agents of the hypocholesterolemic effect of soy foods. However, few studies have investigated the effect of PE supplementation on serum lipoproteins. The purpose of the present study is to investigate the effects of PE supplementation (150 mg) on serum lipids and lipoproteins in moderately hypercholesterolemic, elderly, postmenopausal women. Thirty-six subjects were randomized into two groups and received either a 150-mg PE supplement/d (n = 20) or a placebo (n = 16). Serum samples obtained at baseline and 2 months were analyzed for total triacylglycerol, total cholesterol, and high density lipoprotein cholesterol using standard Lipid Research Clinic procedures. In addition, total triacylglycerol and cholesterol were measured after 6 months of treatment. The t test and ANOVA were employed to compare the two groups. The results (mean +/- SEM) indicated no significant differences in total triacylglycerol (1.3 +/- 0.2 vs. 1.2 +/- 0.2 mmol/liter), total cholesterol (6.4 +/- 0.4 vs. 6.5 +/- 0.2 mmol/liter), or high density lipoprotein cholesterol (1.0 +/- 0.1 vs. 1.0 +/- 0.1 mmol/liter) between the placebo and the PE groups, respectively, after 2 months of treatment. Moreover, total triacylglycerol and cholesterol remained unchanged after 6 months. Our findings suggest that PE supplementation with 150 mg/d over a 6-month period does not significantly alter serum lipoproteins in postmenopausal women and, therefore, may not effectively reduce the risk of CAD in this population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788633     DOI: 10.1210/jcem.87.1.8155

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Postmenopausal hormone replacement therapy and atherosclerosis.

Authors:  Jennifer E Ho; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

2.  Phytoestrogens: food or drug?

Authors:  Lucia Bacciottini; Alberto Falchetti; Barbara Pampaloni; Elisa Bartolini; Anna Maria Carossino; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

3.  Taking a bite out of hypertrophic cardiomyopathy: soy diet and disease.

Authors:  Cathy J Hatcher; Craig T Basson
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 4.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

5.  Maternal soybean diet during lactation alters breast milk composition and programs the lipid profile in adult male rat offspring.

Authors:  Adriana Moura Vieira; Poliana Guiomar de Almeida Brasiel; Maíra Schuchter Ferreira; Kacia Mateus; Mariana Sarto Figueiredo; Patrícia Cristina Lisboa; Egberto Gaspar de Moura; José Otavio do Amaral Corrêa; Fernando Cesar Ferraz Lopes; Paulo Henrique Fonseca da Silva; Céphora Maria Sabarense; Sheila Cristina Potente Luquetti Dutra; Aline Silva de Aguiar
Journal:  Endocrine       Date:  2018-03-08       Impact factor: 3.633

6.  Effect of soy- and whey protein-isolate supplemented diet on the redox parameters of trained mice.

Authors:  Dario Elia; Krisztián Stadler; Viktória Horváth; Judit Jakus
Journal:  Eur J Nutr       Date:  2006-03-30       Impact factor: 5.614

Review 7.  Soy and red clover for mid-life and aging.

Authors:  S E Geller; L Studee
Journal:  Climacteric       Date:  2006-08       Impact factor: 3.005

8.  High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer.

Authors:  Joshua K Napora; Ryan G Short; Denis C Muller; Olga D Carlson; Juliana O Odetunde; Xiaoqiang Xu; Michael Carducci; Thomas G Travison; Marcello Maggio; Josephine M Egan; Shehzad Basaria
Journal:  J Androl       Date:  2010-08-26

9.  Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.

Authors:  S Basaria; A Wisniewski; K Dupree; T Bruno; M-Y Song; F Yao; A Ojumu; M John; A S Dobs
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

10.  Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials.

Authors:  Kyoko Taku; Keizo Umegaki; Yoshiko Ishimi; Shaw Watanabe
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.